Filing Details

Accession Number:
0001593968-21-002140
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 17:09:02
Reporting Period:
2021-03-15
Accepted Time:
2021-09-17 17:09:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
738214 Aemetis Inc AMTX Industrial Organic Chemicals (2860) 261407544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055711 R John Block 20400 Stevens Crek Blvd, Suite 700
Cupertino CA 95014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-15 36,000 $19.12 54,627 No 4 S Direct
Common Stock Disposition 2021-05-25 4,977 $11.76 54,627 No 4 S Direct
Common Stock Disposition 2021-05-26 15,023 $11.82 54,627 No 4 S Direct
Common Stock Disposition 2021-09-16 14,511 $13.94 40,116 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
  2. The Reporting Person acquired 36000 shares of the Company by exercising option grant and cash payment of exercise cost and sold the same shares in the open market on the same day.
  3. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 54,627 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s.
  4. The Reporting Person acquired 4977 shares of the Company by exercising option grant and cash payment of exercise cost and sold the same shares in the open market on the same day.
  5. The Reporting Person acquired 15023 shares of the Company by exercising option grant and cash payment of exercise cost and sold the same shares in the open market on the same day.